Overall, results of this study showed that PHF2 is downregulated in ALL, and that deletion and/or functional inactivation of IKZF1 might be one of the reasons for low levels of PHF2 in high-risk ALL. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.